Sana Biotechnology Inc (SANA)
7.82
+0.32
(+4.27%)
USD |
NASDAQ |
Jun 03, 16:00
7.81
-0.01
(-0.13%)
After-Hours: 20:00
Sana Biotechnology Shareholders Equity (Quarterly): 375.14M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 375.14M |
| December 31, 2023 | 287.51M |
| September 30, 2023 | 365.85M |
| June 30, 2023 | 355.03M |
| March 31, 2023 | 428.26M |
| December 31, 2022 | 499.32M |
| September 30, 2022 | 566.02M |
| June 30, 2022 | 639.50M |
| Date | Value |
|---|---|
| March 31, 2022 | 701.66M |
| December 31, 2021 | 728.50M |
| September 30, 2021 | 830.08M |
| June 30, 2021 | 905.90M |
| March 31, 2021 | 881.98M |
| December 31, 2020 | -421.18M |
| September 30, 2020 | -311.18M |
| December 31, 2019 | -142.54M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-421.18M
Minimum
Dec 2020
905.90M
Maximum
Jun 2021
418.12M
Average
463.79M
Median
Shareholders Equity (Quarterly) Benchmarks
| Cytokinetics Inc | -396.16M |
| Insmed Inc | -464.81M |
| Rocket Pharmaceuticals Inc | 441.50M |
| Taysha Gene Therapies Inc | 53.85M |
| Atea Pharmaceuticals Inc | 504.37M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 681.38M |
| Total Liabilities (Quarterly) | 306.24M |